Patents by Inventor Marcelo SAMSA

Marcelo SAMSA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MESSENGER RNA THERAPEUTICS AND COMPOSITIONS
    Publication number: 20220370599
    Abstract: In the various aspects and embodiments, this disclosure provides messenger RNA (mRNA) constructs for therapeutic delivery, as well as methods for making such mRNA constructs and pharmaceutical compositions comprising the same (including mRNA vaccine compositions). In still other aspects, the invention provides methods for treating patients by expression of therapeutic proteins, including for preventing or reducing probability of infection by, or illness involving, a virus. Exemplary viruses include coronaviruses (such as SARS-CoV-2 and variants therefore) and influenza viruses, among others.
    Type: Application
    Filed: May 2, 2022
    Publication date: November 24, 2022
    Inventors: James Robbins ABSHIRE, Christopher J.H. DAVITT, Ian HILL, Lorenzo AULISA, Marcelo SAMSA, Nabanita DE, Michael HUDSON, Rachit JAIN, Himanshu DHAMANKAR, William FARMER, Christopher GREGG
  • LYSSAVIRUS ANTIGEN CONSTRUCTS
    Publication number: 20220241398
    Abstract: Nucleic acid based vaccine constructs encoding Lyssaviral antigens are useful in preventing and treating diseases. Self-amplifying RNA molecules encoding Lyssaviral antigens provide potent and long-lasting immunity.
    Type: Application
    Filed: February 2, 2022
    Publication date: August 4, 2022
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: KATHRYN HASHEY, PADMA MALYALA, MARCELO SAMSA, OLGA SLACK, DONG YU, ALAN STOKES, RASHMI JALAH
  • Lyssavirus antigen constructs
    Patent number: 11278613
    Abstract: Nucleic acid based vaccine constructs encoding Lyssaviral antigens are useful in preventing and treating diseases. Self-amplifying RNA molecules encoding Lyssaviral antigens provide potent and long-lasting immunity.
    Type: Grant
    Filed: July 16, 2018
    Date of Patent: March 22, 2022
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Kathryn Hashey, Padma Malyala, Marcelo Samsa, Olga Slack, Dong Yu, Alan Stokes, Rashmi Jalah
  • LYSSAVIRUS ANTIGEN CONSTRUCTS
    Publication number: 20200222526
    Abstract: Nucleic acid based vaccine constructs encoding Lyssaviral antigens are useful in preventing and treating diseases. Self-amplifying RNA molecules encoding Lyssaviral antigens provide potent and long-lasting immunity.
    Type: Application
    Filed: July 16, 2018
    Publication date: July 16, 2020
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Kathryn HASHEY, Padma MALYALA, Marcelo SAMSA, Olga SLACK, Dong YU, Alan STOKES, Rashmi JALAH